TruScreen Group Limited CEO, Juliet Hull, recently presented at AusBiotech 2021 Invest and Partnering virtual conference held on 26 October.

Juliet shared with the conference TruScreen's recent progress and our growth strategy as we look to 2022 and beyond. She spoke of why the elimination of cervical cancer should be a focus for us all, particularly with consideration to the World Health Organisation's (WHO) elimination initiative, and how innovative screening methods like TruScreen will be needed to meet the WHO global targets.

Attachments

  • Original document
  • Permalink

Disclaimer

TruScreen Limited published this content on 29 October 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 29 October 2021 02:57:02 UTC.